Thymidylate synthase expression in epithelial ovarian cancer: Relationship with thymidine phosphorylase expression and prognosis

Oncology

Volumn 59, Issue 2, 2000, Pages 152-157

  Fujiwaki, Ritsuto ^a   Hata, Kohkichi ^a   Nakayama, Kentaro ^a,b   Fukumoto, Manabu ^b   Miyazaki, Kohji ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Epithelial ovarian cancer; Immunohistochemistry; Prognosis; Reverse transcription polymerase chain reaction; Thymidine phosphorylase; Thymidylate synthase

Indexed keywords

THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE;

ADULT; AGED; ARTICLE; CORRELATION FUNCTION; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE;

EID: 0033824440     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012153     Document Type: Article

References (26)

1. Danenberg PV: Thymidylate synthetase - A target enzyme in cancer chemotherapy. Biochem Biophys Acta 1977;473:73-92.
2. Johnston PG, Drake JC, Trepel J, Allegra CJ: Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines. Cancer Res 1992;52: 4306-4312.
3. Suzuki M, Ohwada M, Tamada T, Tsuru S: Thymidylate synthase activity as a prognostic factor in ovarian cancer. Oncology 1994;51: 334-338.
4. Johnston PG, Lenz HJ, Leichman CG, Danenberg KD, Allegra CJ, Danenberg PV, Leichman L: Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 1995;55:1407-1412.
5. Okabe H, Tsujimoto H, Fukushima M: Preparation of the antibodies against recombinant human thymidylate synthase for the detection of its intratumoral levels and the application to sensitivity-study of 5-fluorouracil. Oncol Rep 1997;4:685-590.
6. Lenz H, Leichman CG, Danenberg KD, Danenberg PV, Groshen S, Cohen H, Laine L, Crookes P, Silberman H, Baranda J, Garcia Y, Li J, Leichman L: Thymidylate synthase mRNA level in adenocarcinoma of the stomach: A predictor for primary tumor response and overall survival. J Clin Oncol. 1996;14: 176-182.
7. Leichman CG, Lenz HJ, Leichman L, Danenberg K, Baranda J, Groshen S, Boswell W, Metzger R, Tan M, Danenberg PV: Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J Clin Oncol 1997;15:3223-3229.
8. Iltzsch MH, el Kouni MH, Cha S: Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry 1985;24:6799-6807.
9. Brown NS, Bicknell R: Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. Biochem J 1998;334:1-8.
10. Ishikawa F, Miyadera K, Hellman U, Drexler H, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin CH: Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 1989;338:557-562.
11. Moghaddam A, Zhang HT, Fan TP, Hu DE, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL, Bicknell R: Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 1995;92:998-1002.
12. Haraguchi M, Kazutaka M, Uemura K. Sumizawa T, Furukawa T, Yamada K, Akiyama S: Angiogenic activity of enzymes. Nature 1994; 368:198.
13. Kitazono M, Takebayashi Y, Ishitsuka K, Takao S, Tani A, Furukawa T, Miyadera K, Yamada Y, Aikou T, Akiyama S: Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase. Biochem Biophys Res Commun 1998;253:797-803.
14. Hata K, Hata T, Collins WP: Association of thymidine phosphorylase concentration with ultrasound-derived indices of blood flow in ovarian masses. Cancer 1997;80:1079-1084.
15. Hata K, Kamikawa T, Arao S, Tashiro H, Katabuchi H, Okamura H, Fujiwaki R, Miyazaki K. Fukumoto M: Expression of the thymidine phosphorylase gene in epithelial ovarian cancer. Br J Cancer 1999;79:1848-1854.
16. Metzger R, Danenberg K, Leichman CG, Salonga D, Sehwartz EL, Wadler S, Lenz HJ, Groshen S, Leichman L, Danenberg PV: High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil. Clin Cancer Res 1998;4:2371-2376.
17. International Federation of Gynecology and Obstetrics: Changes in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 1989;156:263-264.
18. Serov SF, Scully RE, Sobin LH: International Histological Classification of Tumors, vol 9: Histological Typing of Ovarian Tumors. Geneva, World Health Organization, 1973.
19. Nishida M, Hino A, Mori K, Matsumoto T, Yoshikubo T, Ishitsuka H: Preparation of antihuman thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol Pharm Bull 1996;19: 1407-1411.
20. Griffiths L, Dachs GU, Bickncell R, Harris AL, Stratford IJ: The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res 1997;57:570-572.
21. Navalgund LG, Rossana C, Muench AJ, Johnson LF: Cell cycle regulation of thymidylate synthetase gene expression in cultured mouse fibroblasts. J Biol Chem 1980;255:7386-7390.
22. Chu E, Copur SM, Ju J, Chen TM, Khleif S, Voeller DM, Mizunuma N, Patel M, Maley GF, Maley F, Allegra CJ: Thymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complex. Mol Cell Biol 1999;19:1582-1594.
23. Scanlon KJ, Kashani-Sabet M: Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells. Proc Natl Acad Sci USA 1988;85: 650-653.
24. Stevenson DP, Milligan SR, Collins WP: Effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesis. Am J Pathol 1998;153:1641-1646.
25. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look Ky, Clarke-Pearson DL, Davidson M: Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996;334:1-6.
26. Sawada N, Ishikawa T, Fukase Y, Nishida M, YoshikuboT, Ishitsuka H: Introduction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts. Clin Cancer Res 1998;4:1013-1019.